235 related articles for article (PubMed ID: 24081576)
41. [Cost-per-responder analysis comparing romiplostim to rituximab in the treatment of adult primary immune thrombocytopenia in Spain].
López MF; Mingot ME; Valcárcel D; Vicente García V; Perrin A; Campos Tapias I
Med Clin (Barc); 2015 May; 144(9):389-96. PubMed ID: 24565604
[TBL] [Abstract][Full Text] [Related]
42. Romiplostim for Immune Thrombocytopenia in Neuroblastoma Patients Receiving Chemotherapy.
Fassel H; Bussel JB; Roberts SS; Modak S
J Pediatr Hematol Oncol; 2019 May; 41(4):e257-e259. PubMed ID: 29683946
[TBL] [Abstract][Full Text] [Related]
43. Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy.
Kuter DJ; Bussel JB; Newland A; Baker RI; Lyons RM; Wasser J; Viallard JF; Macik G; Rummel M; Nie K; Jun S
Br J Haematol; 2013 May; 161(3):411-23. PubMed ID: 23432528
[TBL] [Abstract][Full Text] [Related]
44. Treatment of acquired amegakaryocytic thrombocytopenic purpura with romiplostim.
Shigekiyo T; Sekimoto E; Shibata H; Ozaki S; Fujinaga H; Hirose T
Platelets; 2015; 26(5):504-6. PubMed ID: 24832714
[No Abstract] [Full Text] [Related]
45. Immune thrombocytopenia and anticoagulation: the role of romiplostim in the early treatment.
Cantoni N; Heizmann M; Bargetzi M
Br J Haematol; 2012 Jun; 157(5):639-41. PubMed ID: 22329466
[No Abstract] [Full Text] [Related]
46. Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.
Jamali F; Lemery S; Ayalew K; Robottom S; Robie-Suh K; Rieves D; Pazdur R
Oncology (Williston Park); 2009 Jul; 23(8):704-9. PubMed ID: 19711585
[TBL] [Abstract][Full Text] [Related]
47. Romiplostim therapy in children with unresponsive chronic immune thrombocytopenia.
Mokhtar GM; Tantawy AA; El Sherif NH
Platelets; 2012; 23(4):264-73. PubMed ID: 22471399
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness of thrombopoietin-receptor agonists in the treatment of refractory immune thrombocytopenia associated to systemic lupus erythematosus.
Magnano L; Enríquez H; Esteve J; Cervera R; Espinosa G
J Rheumatol; 2014 Sep; 41(9):1895-6. PubMed ID: 25179983
[No Abstract] [Full Text] [Related]
49. [Romiplostim: an advance in the treatment of idiopathic thrombocytopenic purpura].
Mingot Castellano ME
Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():39-43. PubMed ID: 21381287
[TBL] [Abstract][Full Text] [Related]
50. Children with ITP: looking beyond the platelet count.
George JN
Pediatr Blood Cancer; 2012 Mar; 58(3):323-4. PubMed ID: 21898785
[No Abstract] [Full Text] [Related]
51. Romiplostim as early treatment for refractory primary immune thrombocytopenia.
Contis A; Lazaro E; Greib C; Pellegrin JL; Viallard JF
Int J Hematol; 2013 Nov; 98(5):520-4. PubMed ID: 24068656
[TBL] [Abstract][Full Text] [Related]
52. Profound thrombocytopenia in patient with ITP treated with chemotherapy for breast cancer and subsequent remission after romiplostim.
Zimrin A; Chumsri S
Ann Hematol; 2013 Aug; 92(8):1145-6. PubMed ID: 23328792
[No Abstract] [Full Text] [Related]
53. Highly fluctuating thrombocytopenia developing in a patient with immune thrombocytopenia (ITP) while administering romiplostim.
Shinohara K; Kambara N
Intern Med; 2012; 51(11):1399-401. PubMed ID: 22687850
[TBL] [Abstract][Full Text] [Related]
54. Immune thrombocytopenic purpura--the changing therapeutic landscape.
Bromberg ME
N Engl J Med; 2006 Oct; 355(16):1643-5. PubMed ID: 17050888
[No Abstract] [Full Text] [Related]
55. Romiplostim in children with chronic immune thrombocytopenia (ITP): the French experience.
Pasquet M; Aladjidi N; Guiton C; Courcoux MF; Munzer M; Auvrignon A; Lutz P; Ducassou S; Leroy G; Munzer C; Leverger G;
Br J Haematol; 2014 Jan; 164(2):266-71. PubMed ID: 24152194
[TBL] [Abstract][Full Text] [Related]
56. Immune thrombocytopenia during childhood: new approaches to classification and management.
Buchanan GR
J Pediatr; 2014 Sep; 165(3):437-9. PubMed ID: 24973290
[No Abstract] [Full Text] [Related]
57. Romiplostim for management of refractory immune thrombocytopenic purpura in the immediate postpartum period.
Patras A; Figueroa R; Singh AP; Madan I
BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32430352
[TBL] [Abstract][Full Text] [Related]
58. Romiplostim and eltrombopag for immune thrombocytopenia: methods for indirect comparison.
Cooper KL; Fitzgerald P; Dillingham K; Helme K; Akehurst R
Int J Technol Assess Health Care; 2012 Jul; 28(3):249-58. PubMed ID: 22980701
[TBL] [Abstract][Full Text] [Related]
59. Romiplostim as a Therapeutic Intervention for Tacrolimus-induced Immune Thrombocytopenia in a Pediatric Cardiac Transplant Patient.
Gipson DR; Larkin T; Seifert R; Black LV
J Pediatr Hematol Oncol; 2021 Aug; 43(6):e777-e779. PubMed ID: 33181586
[TBL] [Abstract][Full Text] [Related]
60. Romiplostim as an early treatment for refractory immune thrombocytopenia in a 2-month-old infant.
Chiba Y; Tasaka K; Matsubara K; Mori M; Muraoka M; Hamabata T; Nodomi S; Waki K
Pediatr Blood Cancer; 2024 Jun; 71(6):e30953. PubMed ID: 38520052
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
